Varicella zoster virus (VZV) is a highly infectious human herpesvirus that is the causative agent for
chicken pox and
shingles. VZV encodes a functional
thymidylate synthase (TS), which is the sole
enzyme that produces
dTMP from dUMP de novo. To study substrate binding, the complex structure of TSVZV with dUMP was determined to a resolution of 2.9 Å. In the absence of a
folate co-substrate, dUMP binds in the conserved TS active site and is coordinated similarly as in the human encoded TS (TSHS) in an open conformation. The interactions between TSVZV with dUMP and a cofactor analog,
raltitrexed, were also studied using differential scanning fluorimetry (DSF), suggesting that TSVZV binds dUMP and
raltitrexed in a sequential binding mode like other TS. The DSF also revealed interactions between TSVZV and in vitro phosphorylated
brivudine (BVDUP), a highly potent anti-herpesvirus
drug against VZV
infections. The binding of BVDUP to TSVZV was further confirmed by the complex structure of TSVZV and BVDUP solved at a resolution of 2.9 Å. BVDUP binds similarly as dUMP in the TSHS but it induces a closed conformation of the active site. The structure supports that the 5-bromovinyl substituent on BVDUP is likely to inhibit TSVZV by preventing the transfer of a methylene group from its cofactor and the subsequent formation of
dTMP. The interactions between TSVZV and BVDUP are consistent with that TSVZV is indeed a target of
brivudine in vivo. The work also provided the structural basis for rational design of more specific TSVZV inhibitors.